Your browser doesn't support javascript.
loading
Sustained Carbohydrate Antigen 19-9 Response to Neoadjuvant Chemotherapy in Borderline Resectable Pancreatic Cancer Predicts Progression and Survival.
Rose, J Bart; Edwards, Alicia M; Rocha, Flavio G; Clark, Carolyn; Alseidi, Adnan A; Biehl, Thomas R; Lin, Bruce S; Picozzi, Vincent J; Helton, W Scott.
Afiliación
  • Rose JB; Division of Surgical Oncology, University of Alabama, Birmingham, Alabama, USA.
  • Edwards AM; Section of General, Thoracic and Vascular Surgery, Seattle, Washington, USA.
  • Rocha FG; Section of General, Thoracic and Vascular Surgery, Seattle, Washington, USA.
  • Clark C; Section of General, Thoracic and Vascular Surgery, Seattle, Washington, USA.
  • Alseidi AA; Section of General, Thoracic and Vascular Surgery, Seattle, Washington, USA.
  • Biehl TR; Section of General, Thoracic and Vascular Surgery, Seattle, Washington, USA.
  • Lin BS; Section of Hematology and Oncology, Virginia Mason Medical Center, Seattle, Washington, USA.
  • Picozzi VJ; Section of Hematology and Oncology, Virginia Mason Medical Center, Seattle, Washington, USA.
  • Helton WS; Section of General, Thoracic and Vascular Surgery, Seattle, Washington, USA.
Oncologist ; 25(10): 859-866, 2020 10.
Article en En | MEDLINE | ID: mdl-32277842

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Terapia Neoadyuvante Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Terapia Neoadyuvante Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos